626 related articles for article (PubMed ID: 15316314)
21. Seminal vesicle biopsy and laparoscopic pelvic lymph node dissection: implications for patient selection in the radiotherapeutic management of prostate cancer.
Stock RG; Stone NN; Ianuzzi C; Unger P
Int J Radiat Oncol Biol Phys; 1995 Nov; 33(4):815-21. PubMed ID: 7591888
[TBL] [Abstract][Full Text] [Related]
22. Colorectal adenocarcinoma involving the prostate: report of 9 cases.
Osunkoya AO; Netto GJ; Epstein JI
Hum Pathol; 2007 Dec; 38(12):1836-41. PubMed ID: 17868775
[TBL] [Abstract][Full Text] [Related]
23. The role of side-specific biopsy and dominant tumor location at radical prostatectomy in predicting the side of nodal metastases in organ confined prostate cancer: is lymphatic spread really unpredictable?
De Luca S; Passera R; Fiori C; Garrou D; Manfredi M; Aimar R; Amparore D; Checcucci E; Bollito E; Porpiglia F
Minerva Urol Nefrol; 2019 Apr; 71(2):146-153. PubMed ID: 30421597
[TBL] [Abstract][Full Text] [Related]
24. The eternal enigma in prostatic biopsy access route.
Fabiani A; Principi E; Filosa A; Servi L
Arch Ital Urol Androl; 2017 Oct; 89(3):245-246. PubMed ID: 28969413
[TBL] [Abstract][Full Text] [Related]
25. Androgen receptor expression in prostate cancer lymph node metastases is predictive of outcome after surgery.
Sweat SD; Pacelli A; Bergstralh EJ; Slezak JM; Cheng L; Bostwick DG
J Urol; 1999 Apr; 161(4):1233-7. PubMed ID: 10081876
[TBL] [Abstract][Full Text] [Related]
26. [Metastases to the breast from non-mammary malignancies: a clinicopathologic study of 28 cases].
Zhou S; Yu B; Cheng Y; Xu X; Shui R; Bi R; Lu H; Tu X; Yang W
Zhonghua Bing Li Xue Za Zhi; 2014 Apr; 43(4):231-5. PubMed ID: 24915812
[TBL] [Abstract][Full Text] [Related]
27. Adenocarcinoma of the prostate involving 2 cell types (prostate specific antigen producing and carcinoembryonic antigen producing) with selective metastatic spread.
Guthman DA; Farrow GM; Myers RP; Ferrigni RG; Lieber MM
J Urol; 1991 Sep; 146(3):854-6. PubMed ID: 1714970
[TBL] [Abstract][Full Text] [Related]
28. Best practices recommendations in the application of immunohistochemistry in the prostate: report from the International Society of Urologic Pathology consensus conference.
Epstein JI; Egevad L; Humphrey PA; Montironi R;
Am J Surg Pathol; 2014 Aug; 38(8):e6-e19. PubMed ID: 25029122
[TBL] [Abstract][Full Text] [Related]
29. Incidence, location, and significance of periprostatic and periseminal vesicle lymph nodes in prostate cancer.
Kothari PS; Scardino PT; Ohori M; Kattan MW; Wheeler TM
Am J Surg Pathol; 2001 Nov; 25(11):1429-32. PubMed ID: 11684961
[TBL] [Abstract][Full Text] [Related]
30. [18F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: a prospective study of 210 patients.
Poulsen MH; Bouchelouche K; Høilund-Carlsen PF; Petersen H; Gerke O; Steffansen SI; Marcussen N; Svolgaard N; Vach W; Geertsen U; Walter S
BJU Int; 2012 Dec; 110(11):1666-71. PubMed ID: 22520686
[TBL] [Abstract][Full Text] [Related]
31. [The role of prostate specific antigen in diagnosis of localized adenocarcinoma of the prostate. Nara Uro-Oncology Research Group].
Hirao Y; Ozono S; Kagebayashi Y; Yoshi M; Tani Y; Uemura H; Momose H; Okajima E
Hinyokika Kiyo; 1996 Oct; 42(10):795-804. PubMed ID: 8951478
[TBL] [Abstract][Full Text] [Related]
32. Lymph node metastases in patients undergoing surgery for a gallbladder cancer. Extension of the lymph node dissection and prognostic value of the lymph node ratio.
Birnbaum DJ; Viganò L; Russolillo N; Langella S; Ferrero A; Capussotti L
Ann Surg Oncol; 2015 Mar; 22(3):811-8. PubMed ID: 25201500
[TBL] [Abstract][Full Text] [Related]
33. [Prostatic carcinoma presenting as neck lymph node metastases: report of two cases].
Uemura M; Hirai T; Kanno N; Nishimura K; Mizutani S; Miyoshi S; Yoshida K; Kawano K
Hinyokika Kiyo; 2001 Oct; 47(10):755-8. PubMed ID: 11758362
[TBL] [Abstract][Full Text] [Related]
34. Secondary colonic adenocarcinoma of the prostate histologically mimicking prostatic ductal adenocarcinoma.
Mai KT; Landry DC; Collins JP
Tumori; 2002; 88(4):341-4. PubMed ID: 12400988
[TBL] [Abstract][Full Text] [Related]
35. The role of radical prostatectomy and lymph node dissection in lymph node-positive prostate cancer: a systematic review of the literature.
Gakis G; Boorjian SA; Briganti A; Joniau S; Karazanashvili G; Karnes RJ; Mattei A; Shariat SF; Stenzl A; Wirth M; Stief CG
Eur Urol; 2014 Aug; 66(2):191-9. PubMed ID: 23735200
[TBL] [Abstract][Full Text] [Related]
36. Prostate-specific antigen, high-molecular-weight cytokeratin (clone 34betaE12), and/or p63: an optimal immunohistochemical panel to distinguish poorly differentiated prostate adenocarcinoma from urothelial carcinoma.
Kunju LP; Mehra R; Snyder M; Shah RB
Am J Clin Pathol; 2006 May; 125(5):675-81. PubMed ID: 16707367
[TBL] [Abstract][Full Text] [Related]
37. Mapping of pelvic lymph node metastases in prostate cancer.
Joniau S; Van den Bergh L; Lerut E; Deroose CM; Haustermans K; Oyen R; Budiharto T; Ameye F; Bogaerts K; Van Poppel H
Eur Urol; 2013 Mar; 63(3):450-8. PubMed ID: 22795517
[TBL] [Abstract][Full Text] [Related]
38. HOXB13 protein expression in metastatic lesions is a promising marker for prostate origin.
Varinot J; Furudoï A; Drouin S; Phe V; Penna RR; Roupret M; Bitker MO; Cussenot O; Compérat E
Virchows Arch; 2016 May; 468(5):619-22. PubMed ID: 26931741
[TBL] [Abstract][Full Text] [Related]
39. [Delay in High-Grade Metastatic Prostate Cancer Progression by Dutasteride : A Case Report].
Yamada Y; Fujiwara H; Somiya S; Fujikawa S; Kamiyama Y; Tamaki M; Kanaoka T
Hinyokika Kiyo; 2018 Apr; 64(4):187-192. PubMed ID: 29772622
[TBL] [Abstract][Full Text] [Related]
40. [Basal cell carcinoma of prostate: a report of three cases].
Liu Z; Ma LL; Zhang SD; Lu M; Tian Y; He Q; Jin J
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Aug; 48(4):720-724. PubMed ID: 29263520
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
